iLite® CD19 (+) Target Assay Ready Cells are genetically engineered human cells (Raji, ATCC# CCL-86) optimized to over-express the surface antigen CD19. The cells are to be used as target cells together with iLite® CD3 Effector Assay Ready Cells for measurement of bispecific CD3-CD19 antibody activity.